Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.
The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.
In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.1
A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.2
While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.3
While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.4
Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”
The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr
References
BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
Buprelieve is a 0.3mg/ml buprenorphine solution for injection, licensed for post-operative analgesia and to potentiate the sedative effects of other centrally-acting agents in dogs and horses. It can be administered by intramuscular or intravenous injection to dogs and cats and by intravenous injection to horses and is available in 10ml multi-dose glass vials.
Dr Rich Irvine BVSc MRCVS, veterinary services manager at Jurox (UK) Limited said: "We are delighted to be extending our range of products with the launch of Buprelieve which will provide veterinary practices with effective and economical analgesia.
"The launch of Buprelieve will be supported by our highly qualified team of veterinary surgeons who aim to deliver top quality help, advice and assistance for clinics wishing to perform best practice anaesthesia across all patient groups."
Jurox says it has been listening to the concerns of veterinary surgeons who say they want high quality generic medicines at affordable prices along with transparency as to what they are paying for each vial. As a result, the company says it is launching Buprelieve at a very affordable list price with a simple and generous introductory offer or rebate.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Jurox prides itself on providing customers with a range of high quality medicines and we believe the launch of Buprelieve will also satisfy vets’ increasing requests for competitively priced products. We understand that providing high quality pain relief is critical and Buprelieve helps vets deliver the care they demand for their patients."
For more information, contact your local Jurox technical advisor, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
Using 14 years’ of race day veterinary reports, the study found that soft tissue injuries, respiratory conditions and gait abnormalities were the most commonly reported issues. Soft tissue injuries include wounds and lacerations. Those classified as 'gait observations' primarily relate to horses reported as lame, moving poorly or being stiff, but without a specific cause being identified. The majority of horses with respiratory conditions had epistaxis.
Researchers say the findings will help prioritize efforts and direct research to identify risk factors for the most common and/or severe conditions, with the aim of developing strategies to further reduce injuries and fatalities in British flat racing, building on its already strong record on equine welfare.
Sarah Rosanowski, PhD PGDipVCS BSc, at the Royal Veterinary College said: "It was not surprising to find that most veterinary incidents reported on race-day are relatively minor and not career-ending. This is of course a good thing.
"Although the good news is that the majority of injuries are not life-threatening, the fatality rates in British flat racing have remained relatively stable rather than declining over the past decade.
"The ongoing surveillance by the British Horseracing Authority is important as it provides a way to track the occurrence of veterinary events over time. Now that we have a baseline against which to monitor the effects of future interventions, there will be opportunities to further improve horse welfare and racing safety."
Reference
Consistent with previous surveys, lameness was shown to be more likely to be caused by conditions such as osteoarthritis in the limb rather than problems in the foot.
Blue Cross carries out NEHS in May each year in partnership with the British Equine Veterinary Association (BEVA). It is sponsored by Dodson & Horrell and Zoetis and supported by the UK’s leading equestrian organisations and charities.
This year saw a 14% increase in participation compared to 2015, with survey records returned for almost 16,751 horses, ponies, donkeys and mules and 5635 people taking part. Most horses were kept in livery or a private yard and used for leisure and hacking.
Lameness has been consistently seen as the most common syndrome affecting horses in the NEHS results year on year. In the latest survey a total of 32.9% (24.4% in 2015) of horses and ponies with health problems were recorded as lame. Overall, as in previous years, lameness in the limb was more common than lameness caused by problems in the foot.
A breakdown of the types of lameness revealed that 47.4% were recorded as suffering from proximal limb lameness, 31.9% from causes of foot lameness other than laminitis and 20.7% from laminitis. Degenerative joint disease (including foot and proximal limb) was the most frequently reported single cause of lameness (41.2% of all lameness) and the most frequently reported joint affected by DJD was the hock (15.3% of all lameness).
Reports of foot lameness (excluding laminitis) more than doubled this year at 10.5% (4.5% in 2015) of all syndromes reported with pus in the foot being the most frequently recorded problem. This could possibly be attributed to the persistent wet weather during and prior to the survey, which can increase susceptibility to the condition.
Josh Slater from the Royal Veterinary College, who is a member of BEVA’s Health & Medicines Committee and analysed the NEHS data, said: "The data gleaned from the survey remains consistent year on year, confirming the reliability of our findings for benchmarking, referencing and research. This year’s increase in overall lameness may be in part attributed to the higher incidence of pus in the foot but may also be because owners are becoming more aware of lameness issues. Ongoing research on lameness has generated significant media coverage over the past year, helping to raise understanding of the importance of accurate diagnosis and treatment both from welfare and performance perspectives."
The six most notable disease syndromes identified in the 2016 National Equine Health Survey are:
Gemma Taylor, Education Officer at Blue Cross said: "The significant increase in participation again this year shows that owners and keepers of horses are really getting behind the survey and recognising its importance in safeguarding the future health and of the UK’s horses. Over the past year NEHS data has been referred to in leading equestrian and veterinary media, showing its credibility as a valuable benchmarking reference."
The 2016 NEHS survey results are now available. To download a copy visit http://www.bluecross.org.uk/nehs2016results and to register for next year’s survey please visit www.bluecross.org.uk/nehs
The first, carried out by Nanna Luthersson and colleagues and published online in the Journal of Equine Veterinary Science in March, evaluated the laminitis risk factors in a group of Danish horses and ponies.1 It confirmed that Cold-blooded type animals <149cm, such as certain native ponies, as well as those being kept on high quality pasture were at an increased risk of developing laminitis for the first time. It also highlighted the important role that a change in grass intake, in terms of both type and amount, may play at any time of the year not only the spring as commonly thought.
The second study, funded in part by the PetPlan Charitable Trust, British Veterinary Association Animal Welfare Foundation Norman Hayward Fund and the Laminitis Trust, was undertaken in conjunction with Nicola Menzies-Gow (Royal Veterinary College) and published online in the Equine Veterinary Journal (EVJ) in August. The study evaluated the risk factors for the development of laminitis prior to the occurrence of the disease.2 It identified that low concentrations of the adipose tissue derived hormone adiponectin, together with high serum insulin concentrations (at rest and as part of a diagnostic test for PPID) may predict an increased risk of future pasture-associated laminitis.
It is hoped that future studies will be able to generate more robust cut off values, which will more accurately predict future laminitis development in an individual animal.
The RVC in collaboration with Waltham is now taking this forward through a study in which these markers are measured regularly, in conjunction with a detailed management assessment, in a group of ponies with no known history of laminitis at the start.
Clare Barfoot RNutr and the research and development manager at Spillers said: "The Danish study gives us important practical facts about the susceptibility of cold-blooded types, and is particularly applicable to natives in the UK. The second study gives hope that there may soon be a test or series of tests that will help predict those at an increased risk of suffering from pasture associated laminitis in the future thereby reducing the number of animals affected by this debilitating condition. In the meantime until we fully understand the condition it is sensible to manage all the risk factors we currently know about, in particular keeping your horse at a healthy weight."
There are three full equine streams running for the duration of the two days, programmed by the Royal Veterinary College and the British Veterinary Association in partnership with the British Equine Veterinary Association. Organisers say the programme has been designed to ensure it caters for both mixed and equine only veterinary surgeons.
The lecture streams are complemented by the show’s ‘Meet the Professor’ equine sessions, where a number of the speakers are able to have more intimate discussions with a smaller group of delegates.
Topics covered in the 36 sessions include:
For more information on the BVA/BEVA Equine Theatre, RVC Equine Theatre 1 and RVC Equine Theatre 2 programmes at the London Vet Show or to register for the event visit londonvetshow.co.uk.
Hand-mouldable into any shape, Hoof Repair is used to create prosthetic hoof extensions and additions that restore foot integrity.
The company says there is no exothermic reaction when the thermoplastic hardens, which eliminates issues caused by excessive heat and makes the product suitable for treating acute laminitis, cracked hooves and horses that have lost a lot of hoof.
When used with Imprint Structural Adhesive, Hoof Repair forms a bond with hoof wall which can be nailed into and rasped, and will stay in place as hoof grows. Hoof Repair is also suitable for treating foal foot deformities.
The company says Hoof Repair is often used in conjunction with Imprint shoes, which are made of the same low melt, long lasting thermoplastic. It allows extensions to be made to the shoes and together the Imprint system protects and supports the hoof allowing the foot to flex and move freely.
Andrew Poynton, Imprint’s Inventor said: "Hoof Repair forms part of a foot care system that has been developed over 20 years by farriers in association with veterinary surgeons. Hoof Repair assimilates hooves precisely to retain the foot integrity and it is particularly useful for treating acute laminitis and cracked or badly damaged hooves."
Co-edited by Paddy Dixon and Vicki Nicholls, the collection comprises ten studies on physiology, disease, diagnosis and treatment techniques in equine dentistry. The editors say it gives veterinary surgeons free access to some of the most important current research in the UK.
The studies include:
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "Care of the horse’s teeth is fundamental to good health. To this end a strong working knowledge of equine dentistry should be seen as an essential cornerstone for every equine practitioner. This diverse collection has the convenience of being easily accessible, online and in one place to help keep vets fully abreast of the excellent research currently being conducted in the UK."
Vicki Nicholls, incoming president of BEVA, continued: "Advances in equine dentistry continue to gather pace and it has been a pleasure and privilege to work with Paddy Dixon collating the most current dental research that will be relevant to all equine practitioners with any level of expertise."
The equine dentistry collection is available free online at: http://bit.ly/2bBDuMW.
The aim of the week is to focus equine practices on ‘Taking care of the small things that make a big difference’ with a toolkit of resources designed to help them promote their businesses and educate and promote the benefits of preventative healthcare.
Peter Young, MSD Equine Business Manager said: "This year’s Horse Health Week has been created to focus on the small things we can all do to help keep our nation’s horses happy and healthy. We are encouraging equine vets to get involved and engage with their clients throughout the week with the support of our toolkit. This celebration of Britain’s horses and the things we can do to improve their health is a positive opportunity for vets to build client loyalty and attract new clients. I urge practices to do as little or as much as they can, but I urge them to do something!"
Horse Health Week is supported with a range of materials for both practices and clients, along with social media content, which vets can obtain on a USB stick from their MSD Animal Health Equine representative.
The toolkit includes a series of five animations – one for each day of the week. They each cover a different topic including; horse connections, the importance of hand washing, equipment at shows, isolation and vaccination. There is also a social media campaign for practices to run called #BonVoyageBuzz, and a survey that will gather the views of horse owners on preventative healthcare.
For full details talk to your MSD Animal Health Account Manager, call MSD on 01908 685685 or refer to www.healthyhorses.co.uk/horse-week.
The webinars each last between three and five minutes and are part of the 2016 ‘Talk About Laminitis’ disease awareness initiative to help detect, manage and monitor PPID.
The webinars can be viewed on the Boehringer Academy website – www.boehringer-academy.co.uk - and podcast versions are also available enabling veterinary professionals to listen to them ‘on the go’.
The first series includes:
The second webinar series covers:
For further information on the webinars or podcasts visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.
The organisers have invited veterinary experts to share their knowledge and expertise in gastroscopy, sinoscopy and upper respiratory tract (URT) endoscopy, using cadaver heads and state of the art models, during daily practical sessions.
Practical sessions will guide delegates through the most commonly used equine endoscopy procedures, including how to perform gastroscopy, how to perform upper respiratory tract endoscopy and exploration of the guttural pouches and how to get the most out of sinoscopy.
Each session will include a review of the anatomy involved and helpful tips from experts Jonathan Anderson, Tim Barnett, Imogen Comyn, Ollie Crowe, Sarah Mack, Patrick Pollock, Alex Rafferty, Richard Reardon, Neil Townsend, Sophie Wilford and Tom Witte.
The gastroscopy practical will make use of a custom synthetic model of a horse’s oesophagus and stomach, uniquely developed by BEVA, Burtons and DeLegge Medical Design in the USA. The URT endoscopy practical will utilise cadaver heads on stands so delegates can look at laryngeal components, sinus drainage angle, ethmoids, guttural pouch ostia and can then scope/ pass foley catheters/chambers catheters in to guttural pouches. Pre-prepared cadaver heads will also be used for the sinoscopy practicals. Frontal sinus trephine holes will allow a scope to be inserted and one side will be broken through the maxillary septal (ventral conchal) bulla so delegates can compare the differences in anatomy.
At the end of each demonstration Burtons, who have sponsored the event and supplied the endoscopic equipment, will be providing advice on how to clean and maintain scopes properly.
Mark Bowen, President of BEVA, said: "BEVA is committed to providing innovative and practical CPD through its entire CPD programme, including congress and these practical sessions showcase the excellent and varied education provided to members. At a time when the RCVS are considering the value of certain types of CPD in improving professional competence, BEVA is committed to leading the field and challenging perceptions of what a modern conference can be."
The practical sessions will run on all three days of Congress on the balcony above the exhibition hall. Each session will comprise a demonstration and then three practical slots, each for a maximum of ten delegates. Places can be secured on a first come first served basis by signing up on the day.
Visit www.beva.org.uk to find out more and to sign up.
The new tool is part of a package that also includes posters and SMS texts to support veterinary practices in raising awareness of gastric ulcers to horse owners.
Equine Gastric Ulcer Syndrome (EGUS) is a serious and common condition and any type of horse can be at risk.1 EGUS can have a profound impact on a horse’s condition and performance and can be life threatening in foals. It is a challenging condition to diagnose as the clinical signs are often vague and not always present.1
Gastroscopy is the only method currently available for a definitive diagnosis. Of the two types of disease equine squamous gastric disease is graded on a numeric scale with 1 being the least severe and 4 being the most serious. Equine glandular gastric disease can be very varied in terms of location and type so grading this disease on a score system is no longer recommended. Instead it is now usually described in terms of location, severity and appearance.2
The new tool has been designed to help vets to map the area affected by gastric disease and record the details in an accessible format. This information, together with treatment and management recommendations, can be shared easily with the client. Posters explaining gastric ulceration have been designed to help increase awareness and understanding of EGUS amongst horse owners.
Zoetis says effective treatment usually involves a combination of management and medical treatments. UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.3 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.3,4 One syringe contains enough UlcerGold for a daily dose for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
Metacam 40 mg/ml solution for injection for cattle and horses contains 40 mg/ml of meloxicam, and is available in either 50 ml or 100 ml presentations. It is approved for subcutaneous or intravenous use in cattle, and intravenous use in horses.
Boehringer says the introduction comes on the back of a recent large-scale landmark study that found adding Metacam to standard antibiotic therapy for mastitis resulted in a greater first-service conception rate, fewer inseminations required to conceive and a higher probability of pregnancy by 120 days post-calving when compared to cows receiving antibiotic therapy alone1.
Boehringer Ingelheim’s technical manager Kath Aplin said: "By reducing the pain and inflammation caused by mastitis and other conditions, the use of Metacam 40 can result in improvements in cattle health and welfare, and may help limit any reduction in feed intakes. This is central to efficient herd management and productivity."
The company adds that new Metacam 40 mg/ml formulation offers a lower volume dose compared to the existing 20 mg/ml presentation, giving vets more flexibility in their use of Metacam.
It is hoped the findings, which were unveiled at the House of Commons yesterday, will enable the welfare priorities of the UK’s 800,000 horses to be addressed.
This is the first time welfare organisations, breeders, the equine industry and the veterinary profession have come together to agree on a strategy to best improve the welfare of horses in the UK.
The equine welfare study found the welfare needs of many horses are not currently being met and the report has highlighted four welfare priorities.
Dr Siobhan Mullan, Research Fellow in Animal Welfare Science, Ethics and Law at the University of Bristol and one of the report’s authors, said: "Bringing together the views of people associated with horses in England and Wales has provided an overview of horse welfare, from the day-to-day concerns of equine caregivers to identifying four priority challenges to equine welfare.
"This research has also identified how equine welfare can be improved, by addressing both the priority challenges, and a wider set of industry and horse-based needs."
Roly Owers, World Horse Welfare Chief Executive, added: "This research report provides a vital insight to the UK’s equine sector, mapping out the welfare landscape from a wide range of sector experts and stakeholders.
"In order for World Horse Welfare and others to most effectively address the welfare challenges facing UK equines, we need to better understand today’s welfare priorities and this research will provide a valuable guide to help in driving the focus of our educational initiatives and resources over the next few years.”
The priority welfare challenges and solutions outlined in the report are:
Unresolved stress/pain behaviourProblems associated with unresolved stress/pain behaviour affect large numbers of horses, often for long durations with variable severity of suffering caused to individual horses.
More academic research is needed to fully understand the links between behaviour, stress and pain, and objective measures of stress and pain in horses should be developed. Vets, riding instructors, the Pony Club, riding clubs and the equine press have a role in educating horse caregivers about signs of stress and pain and the appropriate responses. Academics and experts also have a role in tackling this issue through evaluating the effectiveness of intervention programmes.
Inappropriate nutritionOverfeeding and obesity are the main welfare problems associated with nutrition and affect large numbers of horses, often for a long time with varying severity of suffering.
Vets have a key role in tackling the problems associated with inappropriate nutrition. A consistent approach by all vets is needed, to prevent horse owners choosing vets that don’t challenge owners about their horses’ nutrition. Feed companies can also play an important role in tackling this issue, although many feed companies already offer appropriate nutrition for a range of horses and exercise situations. Better owner education, based on existing good research, would ensure the right nutritional choices are made for individual horses.
Inappropriate stabling /turnoutWelfare of horses is compromised when the amount of time spent at pasture/stabled does not meet their individual needs, when they are kept in social isolation or when they are exposed to unsuitable grazing conditions. Welfare problems associated with incorrect stabling/turnout affect large numbers of horses for a long time with variable levels of suffering.
Although all horse owners make choices relating to the amount and type of stabling and turnout experienced by their horses, livery yard owners could play a role in addressing this issue. For example, by encouraging different approaches to management, including group housing and the use of all-weather turnout facilities. Strengthening legislation is another possible way for improvement but a ‘one size fits all’ approach would be inappropriate. For example, for some horses, turn out to pasture may not always be suitable.
Delayed deathHorses may be kept alive inappropriately resulting in firstly, prolonging welfare problems, such as continued suffering of a horse in pain. This affects relatively large numbers of horses, for short periods of time with the severity of suffering often being severe. Secondly, an increased risk of suffering, for example where horses are unwanted by their owners, become low value and subsequently aren’t cared for well.
One way for improvement could be by putting pressure on the EU to make changes to the passport regulations. In particular, legislation changes that would enable horses who had received medications, including Phenylbutazone, to be slaughtered to enter the human food chain after a six month withdrawal period. In addition, challenging negative attitudes of horse owners towards timely euthanasia is important.
The research, undertaken over a four year period, was to understand the welfare status of horses in England and Wales, identify priority welfare issues and explore horse owner and industry experts’ perceptions of these issues.
Stakeholders from across the equine industry contributed to the research: from vets to farriers and welfare charities to governing body representatives, participants represented a wide-reaching cross section of horse care roles and responsibilities.
Currently used by more than 200 practices and 50 universities around the world, the Equinosis Q is a diagnostic tool that can further aid the subjective lameness evaluation on all types of horses and ponies examined in the field or in hospital settings.
Christina Frigast, MRCVS, Eickemeyer Product Development Manager said: "The inertial sensors sample 20x faster than the human eye making the Equinosis Q a valuable tool to the veterinarian in the evaluation of subtle and multiple limb lameness.
"It does not interfere with the routine lameness examination as trot up on straight line, lunging and ridden evaluations can be performed on both hard and soft surfaces.
"Data is wirelessly streamed to a tablet PC and compiled into a reader-friendly report displaying the timing and severity of lameness. The effectiveness of diagnostic blocks can also be assessed with the Equinosis Q, providing the veterinarian with a percentage of improvement. In addition, comparison reports can be used to monitor rehabilitation progress."
Contact Eickemeyer to book a free demo, or for further information, visit: https://www.eickemeyer.co.uk/Diagnostics-and-Education/Anatomy-Models/Lameness-Locator-vet.html?listtype=search&searchparam=lameness
watch?v=MS6UXQSq6q0
The initiative is part of the company’s Keeping Britain’s Horses Healthy (KBHH), and provides a way that practices can work with their Equine Account Manager to help horse owners bring their vaccination status up-to-date for equine influenza and tetanus.
Peter Young, Equine Business Manager said: "We’re aware how easy it is for owners to get behind on their horses’ vaccinations but with over half of the UK horse population not protected against equine ‘flu, vets need all the help they can get to improve vaccination rates in their area. We should be aiming for at least 70% ‘flu vaccination rates to ensure our horses benefit from herd immunity so we’re offering vets some practical support to help them improve the situation."
The KBHH vaccination amnesty will be offering a reduced cost option for horses needing to restart a primary course, encouraging horse owners to add their horse to the population already protected.
Horses will need to be over 12 months of age and be unvaccinated or have lapsed from their normal booster vaccination for more than three months.
MSD is also providing a range of online and printed material for vets to help promote the amnesty and ensure their clients take action, including materials that practices can post on Facebook to raise awareness of the symptoms of equine ‘flu and the importance of vaccination.
For further details contact your MSD Animal Health equine representative.
The vaccine will be available to order directly from Merial on receipt of a Special Import Certificate (SIC) issued by the VMD to the named vet. The SIC is only required once but needs to accommodate all potential doses required, enabling Merial to supply to direct orders from the practice.
The product is available in 10 dose packs at a net price of £89.00 per pack.
For further information, contact Merial Customer Support Centre (UK) on 0870 6000 123 or your local equine territory manager.
It was the only organisation from the veterinary profession to be shortlisted.
The Antibiotic Guardian Awards were introduced this year by Public Health England (PHE) and aim to champion UK organisations and individuals who have demonstrated achievement in tackling antimicrobial resistance at a local, regional or national level.
BEVA first launched its Protect ME antimicrobial campaign in 2012 to coincide with European Antimicrobial Awareness day. The Association has launched additional resources each year to facilitate compliance and educate the public about the importance of antimicrobial awareness.
Mark Bowen, President of BEVA and co-author of the Protect ME toolkit, said: "It is a great achievement for a veterinary organisation to be recognised alongside the human health sector which invariably has significantly more resources to support antimicrobial stewardship. Protect ME has had a fantastic uptake from the equine profession and are proud of the impact that it is having. BEVA is grateful to all who have contributed to its success, especially Wendy Furness and Jacky Paton of the Scarsdale veterinary group, Derby who trialled it prior to launch and adopted it fully within the practice."
The BEVA Protect ME toolkit is free to BEVA members and can be downloaded at www.beva.org.uk.
The ioLight microscope fits in a jacket pocket and the company says it is both simple to use and robust. It unfolds to record and share 5MP still images and real time HD video at a magnification of x200 on an iPad Air. The resolution is 1 micron or 1/1,000 mm, powerful enough to see the structure of plant and animal cells.
The microscope uses standard microscope slides and has adjustable top and bottom illumination for use on both biological and opaque samples.
Iolight says it is particularly good for live samples which deteriorate on the journey back to the lab, and it works anywhere, even without a WiFi or mobile phone network.
Andrew Monk, who founded ioLight with business partner Richard Williams, said: "It takes just a couple of minutes to get a great image on the microscope, anywhere from a river bank to a factory floor. This makes microscopy simpler for everyone, from experienced professionals to student scientists."
The ioLight microscope can be ordered now from www.iolight.co.uk, priced at £840 including VAT.
MSD Animal Health has announced the launch of KBHH Yard Master – a new preventative healthcare and biosecurity app - as part of its ongoing Keeping Britain’s Horses Healthy (KBHH) campaign.
MSD says KBHH Yard Master has been created to link vets and yards where the majority of horses in Britain are kept. It aims to play a key role in protecting the health and welfare of the herd and in safeguarding the yard’s reputation and business.
Peter Young, Equine Business Manager at MSD Animal Health said: "Good biosecurity is essential in building and maintaining the reputation of a yard which, in turn, impacts on owner satisfaction and retention. It remains, however, a poorly understood subject despite its importance. We’ve therefore invested in the creation of KBHH Yard Master to help vets, yard managers, their employees and horse owners focus on preventative health and biosecurity measures; making best practice seem more achievable and easier to implement.
He added: "We were also fortunate to have input from Professor Josh Slater, who has been heavily involved in developing the content, evaluation and grading system behind the app assessment."
KBHH Yard Master covers all aspects of biosecurity, including everyday husbandry practices, managing new arrivals, running isolation facilities, infection control and personnel movement. MSD says it will frame a dialogue with yard managers regarding preventative healthcare and biosecurity in situ and provide instant feedback on current practices and risk. Following the on-site assessment, a report can be sent to the yard manager with tailor-made recommendations and timings, detailing how they can improve their yard’s biosecurity performance.
Peter added: "Based on the data gathered through the KBHH campaign we know that approximately half of horses are vaccinated for ‘flu. This means that there will be horses on yards, visited by vets, that are not vaccinated. KBHH Yard Master will help identify those horses and allow the vet to recommend appropriate vaccination schedules."
MSD has produced a range of supporting KBHH Yard Master materials to promote understanding, participation and compliance amongst yard staff and owners, including posters and downloadable booklets which explain aspects such as disease prevention, infection control and outbreak control.
A certificate of excellence is also available to be awarded to those yards which, following assessment, have a low overall biosecurity risk.
For more information, contact your MSD Animal Health Equine Account Manager or call MSD on 01908 685685.
BEVA has announced that tickets are now on sale for BEVA Congress and members who register before 4th August 2016 can benefit from big discounts.
This year, BEVA Congress is being held at the ICC in central Birmingham.
In addition to the clinical programme, tactics to achieve the elusive work life balance and the applicability of evidence based medicine are recurring themes over the three days of the event.
Five separate programmes will run concurrently in five adjacent halls, deploying a mix of traditional lectures, panel discussions and interactive forums to suit equine vets and mixed practitioners at any stage in their career. Vet nurses, farriers, equine physiotherapists and equine dental technicians can also attend specific sessions focused on their areas of expertise.
There will be daily practical sessions in the exhibition hall: Jonathan Anderson, Will Barker, Tim Barnett, Ollie Crowe, Richard Reardon, Neil Townsend and Thomas Witte will be demonstrating sinoscopy and gastroscopy techniques and delegates will have the chance to roll up their sleeves and get hands on with dead heads and digital models.
Programme highlights include a day of advanced orthopaedics in combination with the European Society of Veterinary Orthopaedics and Traumatology (ESVOT). The sessions will draw on canine and human experience, with speakers including Ian Wright from the Newmarket Equine Hospital, Peter Clegg from the University of Liverpool, Wayne McIlwraith from Colorado State University and Martin Waselau from Equine Hospital Aschheim, Germany.
There will also be career and practice development sessions exploring what you can do with your veterinary degree, how to look after your staff and how to take advantage of smartphone technology in practice. Evidence in surgery and critical appraisal tools will be explored in a series of presentations on two separate days across a wide range of conditions. Speakers will include Will Barker, Bruce McGorum, and Etienne O'Brien.
Kathy Clarke, Professor of Veterinary Anaesthesia at the Royal Veterinary College, will be giving the plenary lecture on from the difficult horse to the demanding surgeon; how effective sedation has revolutionised what is achievable in equine clinical practice. There will be a debate on the Friday with Victoria Harris chairing the promisingly divisive This house believes that lab tests are overused and abused.
There will also be comprehensive sessions on parasitology, laminitis, skin disease, anaesthesia and analgesia, colic, respiratory disease, sports injuries, standing surgery, ophthalmology, diagnostics, wounds, neurology and differentiating lameness from neurological disease, mare and foal, reproduction, dentistry, gastro intestinal disease and nutrition, cardiology and medicine.
Saturday’s vet nurse sessions will cover surgical management, emergency patients, the use of antimicrobials and adjunctive therapies. In addition, daily clinical research presentations will provide exclusive opportunities to hear about novel and exciting research projects.
There's a free BEVA Congress App with the full scientific programme and to help you manage your day. And if you are struggling for time or torn between several lectures you can use the BEVA Congress Encore Room which gives you the chance to play back missed lectures at your convenience.
For more information, visit www.beva.org.uk.
Avacta has announced the launch of Sensitest, the only UK-specific equine allergy tests that use non-invasive procedures.
The company says that the new range of ELISA tests was developed using native plant allergen species, to reflect the needs of UK and Northern European veterinary surgeons.
Janice Hogg, Avacta senior veterinary director, said: "In the development trials, allergens were selected that showed significant levels of reactivity in horses with clinical signs compatible with allergic disease.
"Whilst many providers of allergy tests are reducing the number of allergens in their panels and providing only a global range of allergens, this research has shown it is vital to include native species of allergenic plants and insects.
"The new ELISA test, which includes allergens such as orchard grass, daisy, dandelion, nettle and horse chestnut, provides UK practitioners with a viable alternative to intradermal testing (IDT). It doesn’t require clipping and has no adverse reactions - ideal for clients who want to avoid this."
Avacta says Sensitest includes panels of allergens that cover the work up of food, respiratory and atopic allergic disease assisting in a more accurate diagnosis, treatment and management options, including allergen-specific immunotherapy.
Janice added: "It is not necessary to withdraw medications (except high dose corticosteroids) for the standardised procedure, which has excellent reproducibility and is not influenced by existing skin pathologies, all of which is really useful when working with equine clients.
"To further assist equine practitioners, especially those faced with non-insured clients, the SENSITEST Equine Screening Test offers a simple positive/negative result to each panel, allowing expansion to the full panels as required to assist with treatment."
For more information contact your Avacta area territory manager, call customer services on 0800 8494 550 or visit www.avactaanimalhealth.com/equineallergy
The Waltham Equine Studies Group has published new research which highlights the effectiveness of grazing muzzles as a tool to help with weight management in ponies.
The research, which was conducted in collaboration with Dr Annette Longland of Equine and Livestock Nutrition Services (ELNS) in Wales2, also showed that longer grass can be more difficult for muzzled ponies to graze, and can cause frustration-related behaviour in some individuals.
According to Waltham, grazing muzzles have already been shown to reduce the pasture intake of ponies by around 80% by significantly reducing bite size and intake.1 Ponies fitted with grazing muzzles may spend more time engaging in foraging and eating than their non-muzzled counterparts, yet the majority either lose weight or retain their body condition. This in turn helps reduce susceptibility to obesity and related disorders, such as insulin dysregulation and laminitis.
Four mature ponies were selected for the study. Their dry matter (DM) and water-soluble carbohydrate (WSC) intakes were measured in spring, summer, and autumn pastures on four, three-hour occasions per pony per season when fitted with or without a grazing muzzle. In addition ponies, with and without muzzles, were allowed to take 10 bites of swards maintained at different heights.
When wearing grazing muzzles pasture intake was reduced by 77% during spring and summer and by 83% during the autumn. Without muzzles the ponies generally reduced the sward length by half with the first bite but when muzzled the reduction was variable and the ponies appeared to experience greater difficulty in accessing the longer versus the shorter swards.
The short (less than 10cm), upright, grass appeared to be the easiest to eat, as leaf blades and stems protruded through the holes in the muzzle. The medium and long swards proved more difficult. They bent under the pressure of the muzzle and became flattened, causing the ponies to adopt various strategies to access the grass. In some cases they pawed the ground to unearth the sward and access it through the muzzle. Alternatively they rammed the solid base of the muzzle hard onto the grass, causing it to buckle and make some blades or stems accessible. These were then yanked vigorously often causing the entire plant to be uprooted and eaten.
Water soluble carbohydrate levels in the sward were similar across the seasons although they were slightly higher in autumn. However, once muzzled the ponies’ intake of WSC wasn’t significantly different across the seasons; strengthening the evidence that the use of grazing muzzles is effective.
Clare Barfoot RNutr and the research and development manager at Spillers said: "While the frustration displayed when the muzzled ponies were on longer grass swards indicates that care should be taken to provide an accessible grass length, grazing muzzles remain an effective weight management tool. They allow turnout over large areas, increasing exercise and allow slow “trickle” feeding, to control weight gain and reduce the risk of obesity-related disorders, without significantly compromising the natural behaviour and wellbeing."
Waltham says grazing muzzles must be used with care, should be properly fitted and horses and ponies should be adapted gradually to wearing them. Group and individual behaviour should be monitored closely to observe any potential concerns caused by changes to the herd dynamics. Ensure that muzzled ponies are confident in drinking and eating through their muzzles before turning them out for prolonged periods. Muzzles must not be used continuously (not more than 10 hours per day) and total exclusion muzzles are not advised. Regular weight monitoring is recommended as some individuals can still gain weight when muzzled.
Improve International has announced that the role of Official Veterinarians in animal welfare is the theme of this year's OV Conference, taking place on the 29th & 30th September.
The conference programme includes lecture streams and round-table discussions on themes relating to both Large Animals and Small Animals, in addition to a series of lectures aimed at Equine Practitioners.
This second OV conference is a collaboration between Improve International, which handles OV registration and training in England, Scotland and Wales; 5m Publishing and the Animal and Plant Health Agency (APHA). They say their objectives are to provide a forum to discuss the latest developments in OV work and to offer an opportunity for OVs to network and share experiences and ideas.
Large animal topics to be discussed at the event include Bovine TB, Bluetongue and Porcine Epidemic Diarrhoea while small animal practitioners will focus on export regulations, certification, the Pet Travel Scheme, together with welfare and exotic disease issues. Equine lectures will include legislation updates and welfare and exotic diseases.
An exhibition of the latest products and services of interest to OVs will again run alongside the conference which will take place at the Alexandra House Hotel and Conference Centre, near Swindon, where Improve International is based.
David Babington MRCVS, Managing Director of Improve, said: "The enthusiastic discussions following many of the lectures at our first conference and the resoundingly positive feedback we received from the 250 delegates attending convinced us of the value of a forum that brings OVs together with experts from private practice, other animal health-related organisations and the APHA.
"Animal welfare is a particularly important topic for OVs so it is the theme for this year's event and all of the speakers will address it within the context of their lectures. We look forward to, once again, welcoming OVs from across the country to Alexandra House in September 2016."
For more information on the Official Veterinarian Conference and Exhibition or to register visit: www.officialvet.com